Strategic Analysis of the European Markets for Theranostics


USD 4,950.00

* Required Fields

USD 4,950.00


Be the first to review this product

This strategic analysis service provides a detailed analysis of the European theranostics market. An indepth analysis of marketing parameters coupled with competitive factors and strategies for sustained market prevalence are reported.

Table of Contents

Strategic Analysis of the European Markets for TheranosticsOverviewOverviewResearch Scope and MethodologyResearch Scope and MethodologyBackground and Applications of TheranosticsBenefits of TheranosticsTest CategoriesStakeholder AnalysisPharma-diagnostic ConvergenceOpportunitiesRole in Pharmaceutical IndustryApplication in Drug Development ProcessKey Industry Challenges and RecommendationsIndustry ChallengesKey Market Dynamics: Drivers and RestraintsDrivers and RestraintsKey Disease Areas:Role of TheranosticsDisease AreasSpecial Focus:OncologyOncologyRecent Advances in Cancer TheranosticsCompetitive OverviewCompetitive OverviewDrugs with Companion TestsRegulatory Scenario : FDA and EMEA PerspectiveRegulatory Scenario SWOT AnalysisSWOT AnalysisConclusionConclusionDecision Support DatabaseDecision Support DatabaseKey Industry ParticipantsKey Industry Participants

Related Research

Release Date : 21-Nov-18

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.